Literature DB >> 27792906

Innate immune escape by Dengue and West Nile viruses.

Michaela U Gack1, Michael S Diamond2.   

Abstract

Dengue (DENV) and West Nile (WNV) viruses are mosquito-transmitted flaviviruses that cause significant morbidity and mortality worldwide. Disease severity and pathogenesis of DENV and WNV infections in humans depend on many factors, including pre-existing immunity, strain virulence, host genetics and virus-host interactions. Among the flavivirus-host interactions, viral evasion of type I interferon (IFN)-mediated innate immunity has a critical role in modulating pathogenesis. DENV and WNV have evolved effective strategies to evade immune surveillance pathways that lead to IFN induction and to block signaling downstream of the IFN-α/β receptor. Here, we discuss recent advances in our understanding of the molecular mechanisms by which DENV and WNV antagonize the type I IFN response in human cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27792906      PMCID: PMC5578430          DOI: 10.1016/j.coviro.2016.09.013

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  91 in total

1.  Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.

Authors:  Yesseinia I Angleró-Rodríguez; Petraleigh Pantoja; Carlos A Sariol
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

Review 2.  Protective and immunological behavior of chimeric yellow fever dengue vaccine.

Authors:  Scott B Halstead; Philip K Russell
Journal:  Vaccine       Date:  2016-02-10       Impact factor: 3.641

3.  Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Authors:  John W Schoggins; Marcus Dorner; Michael Feulner; Naoko Imanaka; Mary Y Murphy; Alexander Ploss; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

4.  Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.

Authors:  Sri Rezeki Hadinegoro; Jose Luis Arredondo-García; Maria Rosario Capeding; Carmen Deseda; Tawee Chotpitayasunondh; Reynaldo Dietze; H I Hj Muhammad Ismail; Humberto Reynales; Kriengsak Limkittikul; Doris Maribel Rivera-Medina; Huu Ngoc Tran; Alain Bouckenooghe; Danaya Chansinghakul; Margarita Cortés; Karen Fanouillere; Remi Forrat; Carina Frago; Sophia Gailhardou; Nicholas Jackson; Fernando Noriega; Eric Plennevaux; T Anh Wartel; Betzana Zambrano; Melanie Saville
Journal:  N Engl J Med       Date:  2015-07-27       Impact factor: 91.245

5.  Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.

Authors:  Alesha Grant; Sanket S Ponia; Shashank Tripathi; Vinod Balasubramaniam; Lisa Miorin; Marion Sourisseau; Megan C Schwarz; Mari Paz Sánchez-Seco; Matthew J Evans; Sonja M Best; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2016-05-19       Impact factor: 21.023

6.  West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.

Authors:  Alvaro Arjona; Michel Ledizet; Karen Anthony; Nathalie Bonafé; Yorgo Modis; Terrence Town; Erol Fikrig
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

7.  Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.

Authors:  Roland Züst; Luisa Cervantes-Barragan; Matthias Habjan; Reinhard Maier; Benjamin W Neuman; John Ziebuhr; Kristy J Szretter; Susan C Baker; Winfried Barchet; Michael S Diamond; Stuart G Siddell; Burkhard Ludewig; Volker Thiel
Journal:  Nat Immunol       Date:  2011-01-09       Impact factor: 25.606

Review 8.  RIG-I in RNA virus recognition.

Authors:  Alison M Kell; Michael Gale
Journal:  Virology       Date:  2015-03-05       Impact factor: 3.616

9.  Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques.

Authors:  Roland Züst; Hongping Dong; Xiao-Feng Li; David C Chang; Bo Zhang; Thavamalar Balakrishnan; Ying-Xiu Toh; Tao Jiang; Shi-Hua Li; Yong-Qiang Deng; Brett R Ellis; Esther M Ellis; Michael Poidinger; Francesca Zolezzi; Cheng-Feng Qin; Pei-Yong Shi; Katja Fink
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

Review 10.  Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses.

Authors:  Justin A Roby; Gorben P Pijlman; Jeffrey Wilusz; Alexander A Khromykh
Journal:  Viruses       Date:  2014-01-27       Impact factor: 5.048

View more
  29 in total

Review 1.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

2.  Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction.

Authors:  Wei Zhang; Bowen Jiang; Miao Zeng; Yanping Duan; Zhen Wu; Yuanyuan Wu; Tao Wang; Mingshu Wang; Renyong Jia; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Qiao Yang; Ying Wu; Shaqiu Zhang; Yunya Liu; Ling Zhang; Yanling Yu; Leichang Pan; Shun Chen; Anchun Cheng
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.

Authors:  J C Madden; Dan Cui; M A Brinton
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

4.  DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model.

Authors:  Roberto S Dias; Michelle D Teixeira; Mariana F Xisto; John W O Prates; Jessica D Da Silva; Iago O Mello; Cynthia C Da Silva; Sérgio O De Paula
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

5.  Altered m6A Modification of Specific Cellular Transcripts Affects Flaviviridae Infection.

Authors:  Nandan S Gokhale; Alexa B R McIntyre; Melissa D Mattocks; Christopher L Holley; Helen M Lazear; Christopher E Mason; Stacy M Horner
Journal:  Mol Cell       Date:  2019-12-03       Impact factor: 17.970

6.  DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes.

Authors:  Jennifer H Lumb; Qin Li; Lauren M Popov; Siyuan Ding; Marie T Keith; Bryan D Merrill; Harry B Greenberg; Jin Billy Li; Jan E Carette
Journal:  Cell Rep       Date:  2017-07-25       Impact factor: 9.423

7.  Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells.

Authors:  Huanle Luo; Evandro R Winkelmann; Ildefonso Fernandez-Salas; Li Li; Sandra V Mayer; Rogelio Danis-Lozano; Rosa Ma Sanchez-Casas; Nikos Vasilakis; Robert Tesh; Alan D Barrett; Scott C Weaver; Tian Wang
Journal:  Antiviral Res       Date:  2018-01-10       Impact factor: 5.970

8.  Mosquito Defensins Enhance Japanese Encephalitis Virus Infection by Facilitating Virus Adsorption and Entry within the Mosquito.

Authors:  Ke Liu; Changguang Xiao; Shumin Xi; Muddassar Hameed; Abdul Wahaab; Donghua Shao; Zongjie Li; Beibei Li; Jianchao Wei; Yafeng Qiu; Denian Miao; Huaimin Zhu; Zhiyong Ma
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

Review 9.  Immune Response to Dengue and Zika.

Authors:  Annie Elong Ngono; Sujan Shresta
Journal:  Annu Rev Immunol       Date:  2018-01-18       Impact factor: 28.527

Review 10.  Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.

Authors:  Hassan A Alhazmi; Asim Najmi; Sadique A Javed; Shahnaz Sultana; Mohammed Al Bratty; Hafiz A Makeen; Abdulkarim M Meraya; Waquar Ahsan; Syam Mohan; Manal M E Taha; Asaad Khalid
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.